This may be because the proinflammatory cytokine IL‐6 can recruit MDSCs, which inhibit T cells reactive to antitumor activity,72 suggesting that IL‐6 levels are positively correlated with HCC progression and negatively correlated with the antitumor immune response. This evidence concerns the gene IL6 and hepatocellular carcinoma.